Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
![Foto de Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.](/img/uploaded/21C42DF6CDA0E8472C44DA6D4C40ABE3.png)
![Foto de Hospital de Sabadell](/img/noimage_org.png)
Hospital de Sabadell
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Sabadell (4)
2021
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
2020
-
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)
Helicobacter, Vol. 25, Núm. 5
-
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry
Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616
2017
-
Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131